Do you take Elmiron? Studies link the... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 27, 2026 Read More
FDA announces complete ranitidine recall By James L. Ferraro | Zantac Recall | Last Modified on Feb 20, 2026 Read More
Mesothelioma isn’t the only asbestos-related condition By James L. Ferraro | Asbestos Exposure & Claims | Last Modified on Feb 20, 2026 Read More
Issues with EpiPens prompt FDA alert By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
What does mesothelioma actually do to the... By James L. Ferraro | Mesothelioma | Last Modified on Feb 20, 2026 Read More
Ranitidine recalls continue, but don’t get the... By James L. Ferraro | Zantac Recall | Last Modified on Feb 20, 2026 Read More
Cancer isn’t the only concern in Roundup... By James L. Ferraro | Roundup Litigation | Last Modified on Feb 23, 2026 Read More
Did landlord improperly dispose of asbestos during... By James L. Ferraro | Mesothelioma | Last Modified on Feb 23, 2026 Read More
FDA continues to find nitrosamines in popular... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 27, 2026 Read More
Issues with valsartan continue despite investigations and... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
Local cop hired Kelley Ferraro to battle... By James L. Ferraro | Zantac Recall | Last Modified on Feb 27, 2026 Read More
Judge consolidates Zantac claims: What does it... By James L. Ferraro | Zantac Recall | Last Modified on Feb 27, 2026 Read More